Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Cannabix Technologies (BLOZF) AI Stock Analysis

400 Followers
BLOZF

Cannabix Technologies

(Other OTC:BLOZF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Low LeverageVery low leverage reduces solvency pressure and leaves the company less exposed to interest obligations than a highly indebted peer. Although the capital base is weakening, modest debt gives management more flexibility to fund development without immediate balance-sheet strain.
Negative Factors
Absent Revenue BaseThe lack of meaningful reported revenue indicates that commercialization has not yet produced a dependable operating base. Without recurring sales, the company has limited internal funding capacity and remains highly dependent on successful product development and future external financing.

Cannabix Technologies (BLOZF) vs. SPDR S&P 500 ETF (SPY)

-60%-40%-20%0%20%40%60%BLOZF-31.70%SPY+14.30%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$34.29M
Dividend Yield
―
Average Volume (3M)
104.90K
Price to Earnings (P/E)
-12.1
Beta (1Y)
-0.19
Revenue Growth
―
EPS Growth
-80.57%
Country
US
Employees
0
Sector
Healthcare
Sector Strength
51
Industry
Other Precious Metals

Cannabix Technologies Business Overview & Revenue Model

Company Description

Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydr...

Cannabix Technologies Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

BLOZF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:PINKTSE:PINK44NeutralCAD 23.78M-1.11-303.05%―35.27%58.34%
TSE:VPTTSE:VPT37UnderperformCAD 12.54M-5.7456.40%―89.06%37.62%

* Healthcare Sector Average

Performance Comparison

0%100%200%BLOZFTSE:PINKTSE:VPTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
BLOZF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
BLOZFCannabix0.28-0.12-30.50%
TSE:PINKPerimeter Medical Imaging Ai Inc0.14-0.05-23.68%
TSE:VPTVentriPoint Diagnostics0.07-0.03-25.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.